Company / R&D per Share
Emergent BioSolutions Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.02
FY2025
5-year range
$1.02 / $4.58
FY2021-FY2025
Trend
-21.6%
vs FY2024
Sector context
#146 of 208
Health Care
What the data says
At $1.02, Emergent BioSolutions Inc.'s r&d per share ranks #146 of 208 in the Health Care sector. R&D per Share has declined for 4 consecutive years, from $4.58 in FY2021 to $1.02 in FY2025.
Based on SEC 10-K filings.
1.02 in FY2025 with a 5-year CAGR of -25.8%.
Declined from $2.13 to $1.02 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -34.7%
- 5-Year CAGR
- -25.8%
- 10-Year CAGR
- -
Sector benchmark
#146 of 208 in Health CareTop 70% of 208This company $1.02 Sector average $28.82
▼
-96.5% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s r&d per share has declined for 4 consecutive years.
- In FY2025, r&d per share decreased 21.6% year-over-year.
- Ranks #146 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.02 | -21.6% |
| FY2024 | $1.30 | -39.0% |
| FY2023 | $2.13 | -41.9% |
| FY2022 | $3.67 | -19.9% |
| FY2021 | $4.58 | +1.1% |
| FY2020 | $4.54 | +3.7% |
| FY2019 | $4.38 | +102.2% |
| FY2018 | $2.16 | -9.9% |
| FY2017 | $2.40 | -11.5% |
| FY2016 | $2.71 | -14.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026